San Antonio Breast Cancer Symposium Posters2View(tm): Title Index

Sponsored by

Titles Index

Click on one of the following letters below to display a list of alphabetized titles.
Click the checkbox next to each item to bookmark.

# - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

A

Page: 1 2 3 4 5 6

[2106] A 24-month subgroup analysis of the effect of denosumab on bone mineral density in women with breast cancer undergoing aromatase inhibitor therapy.

[3106] A breast international group survey of young breast cancer patients' attitudes towards the risk of loss of fertility related to adjuvant therapies. EORTC protocol 10002 – BIG 3-98.

[1116] A case controlled, cross-sectional survey of joint and muscle aches, pains and stiffness in women with primary breast cancer.

[6090] A clinico-pathological analysis of breast cancer patients with a family history.

[6150] A comparative analysis of the attitudes of doctors and patients towards adherence behaviour and information provision.

[6126] A comparison of high-dose (HD, 500 mg) fulvestrant vs anastrozole (1 mg) as first-line treatments for advanced breast cancer: results from FIRST.

[2026] A comprehensive analysis of nine prognostic signatures reveals the high classification instability in breast cancer.

[5141] A Contura™ catheter provides dosimetric advantages over a MammoSite™ catheter for accelerated partial breast irradiation.

[1129] A distinct inflammatory marker pattern in patients with aromatase inhibitor (AI)-induced musculoskeletal symptoms.

[1144] A global perspective on the use of aromatase inhibitors in early-stage breast cancer.

[5043] A low number of tumor infiltrating FOXP3-positive cells after primary systemic chemotherapy is correlated with favorable relapse-free survival in breast cancer patients.

[705] A meta-analysis of phase III trials evaluating the predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy.

[2131] A multi-center phase II study of three doses of TAS-108 in postmenopausal women with advanced breast carcinoma following first or second line endocrine therapy.

[305] A multi-marker QPCR panel for the detection of circulating tumor cells predicts survival in breast cancer patients.

[3156] A multicenter phase II study of non-pegylated liposomal doxorubicin (MYOCET®) in combination with trastuzumab and docetaxel as first line therapy in metastatic breast cancer.

[6122] A multicenter phase II trial of weekly paclitaxel (wPC) and epirubicin (E) in first line metastatic breast cancer (MBC) and pronostic impact of VEGF level.

[2160] A multistage nanodelivery system for therapeutic applications and medical imaging: in vivo biodistribution and efficacy study in a murine orthotopic breast cancer model.

[4079] A new design of clinical trial – use of nomograms – illustration with local treatment of T2 tumors in the SEER database.

[4162] A new enrichment model for high sensitivity detection and downstream analyses of circulating tumor cells in breast cancer patients.

[1021] A new hand-held gamma camera for sentinel node detection in breast cancer. The Minicam experience in 50 cases.

Poster Sessions | Support | FAQ | Privacy Policy

San Antonio Breast Cancer Symposium
7703 Floyd Curl Dr. Mail Code 8224
San Antonio, TX 78229 USA
http://www.sabcs.org
Technical Support • © 2010 Marathon Multimedia, a Learner’s Digest International business. • All rights reserved